Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard C Becker

Showing results (1-10 of 436) with videos related to

Pageof 44
Sort By:
Journal of Thrombosis and Thrombolysis|October 19, 2015
The biochemistry, enzymology and pharmacology of non-vitamin K anticoagulant drug reversal agents and antidotesRichard C Becker
Journal of Thrombosis and Thrombolysis|August 17, 2021
Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor's page seriesRichard C Becker
Journal of Thrombosis and Thrombolysis|September 30, 2006
Biosignatures in thrombotic disordersRichard C Becker
American Heart Journal|August 10, 2005
The vulnerable endothelium: priming the vascular endothelium for thrombosis with unfractionated heparin: biologic plausibility for observations from the Superior Yield of the New Strategy of Enoxaparin, Revascularization and GlYcoprotein IIb/IIIa Inhibitors (SYNERGY) trialRichard C Becker
American Heart Journal|December 27, 2025
Response to the Letter: Another perspective on democracy, healthcare and the public goodRichard C Becker
American Heart Journal|January 13, 2005
Understanding the dynamics of thrombin in cardiovascular disease: pathobiology and biochemistry for the clinicianRichard C Becker
The Journal of Invasive Cardiology|April 4, 2009
Next-generation antithrombin therapiesRichard C Becker
Journal of Thrombosis and Thrombolysis|July 22, 2008
Editor's page: fundamentals in neurocardiology: the brain-platelet-coronary artery interfaceRichard C Becker
Thrombosis Research|October 22, 2008
Biological and pharmacological aspects of perioperative hemorrhagic complications associated with oral platelet-directed antithrombotic agents. Focus on isolated coronary artery bypass grafting and oral irreversible P2Y(12) receptor antagonistsRichard C Becker
Journal of Thrombosis and Thrombolysis|November 30, 2006
Warfarin-induced vasculopathyRichard C Becker
Pageof 44

Showing results (1-10 of 436) with videos related to

Sort By:
Pageof 44
Journal of Thrombosis and Thrombolysis|October 19, 2015
The biochemistry, enzymology and pharmacology of non-vitamin K anticoagulant drug reversal agents and antidotesRichard C Becker
Journal of Thrombosis and Thrombolysis|August 17, 2021
Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor's page seriesRichard C Becker
Journal of Thrombosis and Thrombolysis|September 30, 2006
Biosignatures in thrombotic disordersRichard C Becker
American Heart Journal|August 10, 2005
The vulnerable endothelium: priming the vascular endothelium for thrombosis with unfractionated heparin: biologic plausibility for observations from the Superior Yield of the New Strategy of Enoxaparin, Revascularization and GlYcoprotein IIb/IIIa Inhibitors (SYNERGY) trialRichard C Becker
American Heart Journal|December 27, 2025
Response to the Letter: Another perspective on democracy, healthcare and the public goodRichard C Becker
American Heart Journal|January 13, 2005
Understanding the dynamics of thrombin in cardiovascular disease: pathobiology and biochemistry for the clinicianRichard C Becker
The Journal of Invasive Cardiology|April 4, 2009
Next-generation antithrombin therapiesRichard C Becker
Journal of Thrombosis and Thrombolysis|July 22, 2008
Editor's page: fundamentals in neurocardiology: the brain-platelet-coronary artery interfaceRichard C Becker
Thrombosis Research|October 22, 2008
Biological and pharmacological aspects of perioperative hemorrhagic complications associated with oral platelet-directed antithrombotic agents. Focus on isolated coronary artery bypass grafting and oral irreversible P2Y(12) receptor antagonistsRichard C Becker
Journal of Thrombosis and Thrombolysis|November 30, 2006
Warfarin-induced vasculopathyRichard C Becker
Pageof 44